Category: Personal Finance

Cardano (ADA); Tops To Be The Third Largest Cryptocurrency

Personal Finance

[ad_1]

Read More/Less


ADA Token

ADA is the Cardano blockchain’s native cryptocurrency, and it may be used to make global peer-to-peer exchanges. An Initial Coin Offering (ICO) issued 57.6 percent of the total 45 billion token supply to investors, bringing the ecosystem $62.2 million in cash.

Since the beginning of the year, the ADA token has risen by almost 1000 percent as of June 2021. Participants in the network can utilise the token for staking and the platform’s governance processes in addition to value transfer and trade. Because they serve as nodes that record the network’s current status, ADA stakers are also termed validators.

With a 24-hour trading volume of $8,130,894,956 USD, the current Cardano price is $2.85 USD. In the previous 24 hours, Cardano has gained 1.14 percent. With a live market cap of $91,667,111,447 USD, CoinMarketCap currently ranks #3. There are 32,143,062,275 ADA coins in circulation, with a maximum supply of 45,000,000,000 ADA coins.

Cardano History

Cardano History

Cardano was formed in 2017, and the ADA token was created to allow owners to participate in the network’s operation. As a result, holders of the cryptocurrency have the ability to vote on any proposed software updates.

According to the creators of the layered blockchain, there have already been several compelling use cases for the technology, which seeks to allow modular development of decentralised apps and smart contracts.

Agricultural organisations use Cardano to track fresh fruit from farm to fork, while other applications created on the platform enable for tamper-proof storage of educational credentials and merchants to crack down on counterfeit goods.

What Makes Cardano Unique?

What Makes Cardano Unique?

Cardano is one of the most well-known blockchains to have successfully implemented a proof-of-stake consensus mechanism, which is less energy-intensive than Bitcoin’s proof-of-work method. Although Ethereum, which is much larger, will upgrade to PoS, this will be a gradual process.

The project has taken satisfaction in ensuring that all technology developed goes through a peer-reviewed research process, allowing for bold ideas to be tested before being verified. According to the Cardano team, academic rigour aids the blockchain’s durability and stability, boosting the likelihood of possible hazards being identified ahead of time.

Will Cardano price rise in the future?

Will Cardano price rise in the future?

On September 12, 2021, Cardano will receive a new update, which is likely to drive the price even higher. Keep in mind, however, that cryptocurrencies are extremely volatile, with the current crash being the most recent example.

Where to buy Cardano in India?

Users in India can invest in Cardano through a number of cryptocurrency exchanges. BuyUCoin, WazirX, and Bitbns are among the coins on the list. If a first-time investor visits these platforms, the website may request information such as an identification card, name, date of birth, and other personal information. These details are required for registration and are then used to identify the investor on such platforms once they have been shared.



[ad_2]

CLICK HERE TO APPLY

Leave a comment

Bajaj Finserv gets Sebi nod to launch mutual fund business, BFSI News, ET BFSI

Personal Finance

[ad_1]

Read More/Less


Bajaj Finserv said it has received an in-principle approval from the Securities and Exchange Board of India (SEBI) for sponsoring a mutual fund. The Company has received an In-Principle approval from Securities and Exchange Board of India (SEBI) vide their letter dated 23 August 2021, for sponsoring a Mutual Fund.

Accordingly, the company would be setting up an Asset Management Company and the Trustee Company, directly or indirectly i.e., itself or through its subsidiary in accordance with applicable SEBI Regulations and other applicable laws,” said the communication from Bajaj Finserv.

Bajaj Finserv Limited is a part of Bajaj Holdings & Investments Limited which focusses on lending, asset management, wealth management and insurance.

Earlier in August, online discount broker Samco Securities received capital markets regulator Sebi’s approval to launch its mutual fund business. All this comes after the Securities and Exchange Board of India (SEBI) allowed Fintechs to apply for mutual fund (MF) licenses, last year in December.

Follow and connect with us on , Facebook, Linkedin



[ad_2]

CLICK HERE TO APPLY

Leave a comment , , , , ,

Study, BFSI News, ET BFSI

Personal Finance

[ad_1]

Read More/Less


Housing loan borrowers are making the most of the current record-low interest rate regime as indicated by a 42% on-year surge in demand for Balance Transfers (BT) and 26% rise for home loans in the first half of 2021, showed a Magicbricks Home Loans Consumer Study.

The demand for Loan Against Property (LAP) during this period has also witnessed a 20% rise. The soaring demand is largely attributed to the Reserve Bank of India’s decision to keep the repo rate unchanged at a constant 4%.

This has allowed many banks to offer home loans at interest rates lower than 7%, which has also been a key driver in augmenting the demand for home buying.

Magicbricks Home Loans Consumer Study also reveals that the most frequently searched home loan amount across tier-1 cities during this period was Rs 36 lakh, while that for BT and LAP were Rs 26 lakh and Rs 32 lakh, respectively. For tier-2 cities, it was Rs 26 lakh for home loans, Rs 23 lakh for LAP and Rs 18 lakh for BT.

“The rising demand for home loans is in line with the increasing demand for residential real estate across key markets of India. Several initiatives by the government, such as keeping the repo rate constant and reduced stamp duty rates, are steps in the right direction. These measures have been instrumental in boosting the overall consumer sentiment, making almost 50% of the borrowers opt for tenures less than 15 years,” said Sudhir Pai, CEO, Magicbricks.

With factors like low interest rates, stable prices, and attractive payment plans, he hopes the pent-up demand would soon translate into sales.”

With Work from Home (WFH) becoming a norm, home buyers are now looking to buy or upgrade to large configuration houses, and thus the demand is mostly in the mid and above segments, said the report.

Hyderabad, Pune, Ahmedabad, Mumbai, and Delhi are the top five tier-I cities witnessing maximum demand for home loans. A similar trend has been recorded in tier-II cities like Lucknow, Patna, Indore, Jaipur, and Agra.

In terms of the demand for Balance Transfers, New Delhi, Bangalore, Mumbai, Pune, and Hyderabad were the top five tier I cities, and Ghaziabad, Mohali, Noida, Indore, and Visakhapatnam the top five tier II cities.

For LAP, Bangalore, Hyderabad, Chennai, New Delhi, and Pune saw the most demand across tier I cities and Gurgaon, Jamshedpur, Patna, Faridabad, and Lucknow for tier II cities.

According to the report, Bank of Baroda, Indian Bank, SBI, HDFC and ICICI Bank are the most searched lenders on Magicbricks’ Home Loans platform.

Magicbricks is a part of Bennett, Coleman & Co, which published The Economic Times.



[ad_2]

CLICK HERE TO APPLY

Leave a comment , , , , , , , , ,

SBI report, BFSI News, ET BFSI

Personal Finance

[ad_1]

Read More/Less


Mumbai, Aug 24 (PTI) The country’s gross domestic product (GDP) is expected to grow at around 18.5 per cent with an upward bias in the first quarter of the current financial year, according to SBI research report Ecowrap. This estimate is lower than the Reserve Bank of India’s GDP growth projection of 21.4 per cent for the April-June quarter.

“Based on our ‘Nowcasting’ model, the forecasted GDP growth for Q1 FY22 would be around 18.5 per cent (with upward bias),” the report said.

Higher growth in the second quarter of 2022, or Q1 FY22 is mainly on account of a low base.

State Bank of India has developed the ‘Nowcasting Model’ with 41 high-frequency indicators associated with industrial activity, service activity, and the global economy.

The report expects gross value added (GVA) to be at 15 per cent in Q1FY22.

The corporate results announced so far indicate that there is a substantial recovery in corporate GVA EBIDTA (earnings before interest, taxes, depreciation, and amortisation) + employee cost) in Q1 FY22, it said.

The report said the corporate GVA of 4,069 companies registered a growth of 28.4 per cent in Q1 FY22. However, this is lower than growth in Q4 FY21, thereby corroborating the lower GDP estimate than what was thought earlier, it said.

The report further said it is globally noted that lower mobility leads to lower GDP and higher mobility to higher GDP, but the response is asymmetric.

With the decline in mobility, the economic activity declines and thus GDP growth, however, with an increase in mobility the GDP growth does not increase in the same proportion, it said.

“The relationship between the two has become weaker as can be seen in Q1 FY22 when mobility has declined, however, GDP growth is high and positive. But higher y-o-y growth is mainly on account of the base effect,” the report said.

Meanwhile, the business activity index based on ultrahigh-frequency indicators show a further increase in August 2021, with the latest reading for the week ended August 16, 2021, at 103.3, it added.

RTO (regional transport office) collection, electricity consumption along with mobility indicators have revived in Q2 FY22, indicating positive momentum in economic activity going forward, the report said.



[ad_2]

CLICK HERE TO APPLY

Leave a comment , , , , ,

IDBI Bank Revises Interest Rates On FD: Check New Rates Here

Personal Finance

[ad_1]

Read More/Less


Investment

oi-Vipul Das

|

Industrial Development Bank of India (IDBI) a leading private sector bank has revised interest rates on fixed deposits with effect from 16th August 2021. IDBI Bank offers two types of fixed deposit schemes which are Suvidha Fixed Deposit and Tax Saving Fixed Deposit. Both these deposits allow a minimum deposit amount of Rs 10,000, auto-renewal facility, monthly, quarterly, and annual income plans, 0.50% additional interest rate for senior citizens, overdraft facility, sweep in, and so on. Under the Suvidha Fixed Deposit scheme, one can choose a tenure ranging from 7 days to 10 years whereas in the Tax Saving Fixed Deposit scheme one is required to stay invested for a lock-in period of 5 years to get tax benefits under section 80C. Apart from all these factors here is all you need to know about the most recent interest rates on fixed deposits of the bank.

IDBI Bank Regular Fixed Deposit Interest Rates

IDBI Bank Regular Fixed Deposit Interest Rates

IDBI Bank is currently offering a 2.70 percent interest rate on FDs maturing in 7 to 30 days after the latest adjustment. The bank is providing a 2.80% interest rate on term deposits with a maturity period of 31-45 days. IDBI Bank offers interest rates of 3.00 percent and 3.50 percent on deposits maturing in 46 days to 90 days and 91-6 months, respectively. The bank offers 4.30 percent on deposits maturing in 6 months to less than a year.

The bank is offering a 5.05 percent interest rate on FDs with a one-year maturity period. The bank is currently offering 5.15 percent and 5.20 percent interest rates on term deposits maturing in one to two years and two to less than three years. Interest rates for FDs maturing in more than 3 years but less than 5 years will be 5.40 percent. IDBI Bank is giving a 5.25 percent interest rate on deposits maturing in 5 to less than 10 years, and a 4.80 percent interest rate on deposits maturing in 10 to 20 years to the general public.

Maturity Slab Interest Rates In % For General Customers
0-6 Days NA
07-14 days 2.70
15-30 days 2.70
31-45 days 2.80
46- 60 days 3.00
61-90 days 3.00
91-6 months 3.50
6 months 1 day to 270 days 4.30
271 days upto 4.30
1 year 5.05
> 1 year – 2 years 5.15
>2 years to 5.20
3 years to to 5.40
5 years (Tax Saving FD) 5.25
> 5 years – 7 years 5.25
>7 years – 10 years 5.25
>10 years – 20 years 4.80
Source: Bank Website, Retail Term Deposits (

IDBI Bank Fixed Deposit Interest Rates For Senior Citizens

IDBI Bank Fixed Deposit Interest Rates For Senior Citizens

For a deposit amount of less than Rs 2 Cr, senior citizens will continue to get an additional interest rate of 0.50% respectively. Here are the latest interest rates on fixed deposits of IDBI Bank for senior citizens.

Maturity Slab Interest Rates In % For Senior Citizens
0-6 Days NA
07-14 days 3.20
15-30 days 3.20
31-45 days 3.30
46- 60 days 3.50
61-90 days 3.50
91-6 months 4.00
6 months 1 day to 270 days 4.80
271 days upto 4.80
1 year 5.55
> 1 year – 2 years 5.65
>2 years to 5.70
3 years to 5.90
5 years (Tax Saving FD) 5.75
> 5 years – 7 years 5.75
>7 years – 10 years 5.75
>10 years – 20 years 5.30
Source: Bank Website, Retail Term Deposits (

IDBI Bank Bulk Deposit Rates

IDBI Bank Bulk Deposit Rates

Here are the bank’s updated interest rates, effective April 16, 2021, for Bulk Deposits of Rs. 2 crore and above, up to Rs. 5 crore.

Maturity Slabs Rate of Interest (% p.a.)
0-6 Days NA
07-14 days 2.50
15-30 days 2.50
31-45 days 2.75
46- 60 days 2.75
61-90 days 2.90
91-6 months 2.90
6 months 1 day to 270 days 3.00
271 days upto 3.10
1 year 3.50
> 1 year – 2 years 3.50
>2 years to 3.75
3 years to 3.75
5 years 3.75
> 5 years – 7 years 3.75
>7 years – 10 years 3.75
Source: Bank Website

Story first published: Tuesday, August 24, 2021, 13:12 [IST]



[ad_2]

CLICK HERE TO APPLY

Leave a comment

Rupee rises 9 paise against US dollar in early trade, BFSI News, ET BFSI

Personal Finance

[ad_1]

Read More/Less


The rupee appreciated 9 paise to 74.13 against the US dollar in opening trade on Tuesday, following a positive trend in domestic equities. However, flight of foreign capital, a strong dollar overseas and higher crude prices restrained the rupee to gain momentum, forex dealers said.

At the interbank foreign exchange, the rupee opened strong at 74.12 against the dollar, then it weakened slightly to quote 74.13, a rise of 9 paise over its previous close.

On Monday, the rupee had settled at 74.22 against the US dollar.

On the domestic equity market front, BSE Sensex was trading 45.14 points or 0.08 per cent higher at 55,600.93, while the broader NSE Nifty rose 19.65 points or 0.12 per cent to 16,516.10.

The dollar index, which gauges the greenback’s strength against a basket of six currencies, rose 0.08 per cent to 93.04.

Global oil benchmark Brent crude futures surged 0.33 per cent to USD 68.98 per barrel.

Foreign institutional investors remained net sellers in the capital market on Friday as they offloaded shares worth Rs 1,363.36 crore, as per exchange data.

Meanwhile, Finance Minister Nirmala Sitharaman on Monday unveiled an ambitious Rs 6 lakh crore National Monetisation Pipeline (NMP) that included unlocking value by involving private companies across infrastructure sectors — from passenger trains and railway stations to airports, roads and stadiums.

“A four-year National Monetization Pipeline (NMP) to monetize Rs 6 trillion of brownfield infrastructure assets across sectors will definitely boost investors’ confidence by providing sufficient clarity on the number, size and type of assets that would be made available in the market,” Abhaya Agarwal, Partner, Infrastructure Practice, EY India, said.



[ad_2]

CLICK HERE TO APPLY

Leave a comment , , , , ,

MSME ministry to support local manufacturing of toys, BFSI News, ET BFSI

Personal Finance

[ad_1]

Read More/Less


Trichy: Aimed at encouraging production of toys locally, the development institute of Micro, Small and Medium Enterprises (MSME-DI) has reached out to the MSMEs associations in Trichy with financial and technical support. Under the design scheme, the interested MSMEs will be guided to master additive manufacturing (production using 3D printers) and reverse-engineering practices to design and produce even complex toys.

As constraints in designing and mass production of components were cited as the disadvantages of MSMEs in manufacturing toys, the Union MSME ministry has formulated the design scheme to offer expert advice and cost-effective solutions. Under the scheme, the National Institute of Technology (NIT) across the country will serve as the implementing agency and will offer technical support for the MSMEs to produce toys on a large-scale. “Subsidy for technical and machinery upgradation for producing toys will be provided by the Union ministry. NIT-Trichy will serve as the implementing agency to support local MSMEs,” S Dharmaselvan, joint director, MSME DI, said.

Cuddalore, Thanjavur, Coimbatore, Dharmapuri and Krishnagiri districts that already have toy manufacturing units can focus on the design scheme, while districts such as Trichy that have a robust MSME presence has opportunities for the existing MSMEs to diversify their presence using technical support from the educational institutes in the region.

“Prospects are high for the Trichy-based MSMEs to manufacture toys made of metal and plastic materials. We are planning a series of sensitisation drives involving the MSME department to encourage the MSMEs to make toys,” N Kanagasabapathy, chairman, Trichy Trade Centre, said. The local production of toys will also reduce the cost of the products that are being imported so far. Toy tricycle has been identified as one of the viable products to design and fabricate in Trichy. The price of locally made toys will be 40%-50% lower than the imported toys, MSMEs said.

The micro and small industries can avail 60% to 70% of the design intervention cost as subsidy. Financial support will be paid in three different stages till successful completion of the design.



[ad_2]

CLICK HERE TO APPLY

Leave a comment , , , , , , ,

Buy This Pharma Stock For 23% Gains, Says Motilal Oswal

Personal Finance

[ad_1]

Read More/Less


Investment

oi-Sunil Fernandes

|

Broking firm, Motilal Oswal is bullish on the stock of Cadila Heatlhcare for 23% returns from the current levels of Rs 541. The firm has set a target price of Rs 670, thus giving potential returns of 23% from the current levels.

Vaccine opportunity for Cadila Healthcare

Cadila Healthcare has received emergency use authorization (EUA) for its plasmid DNA COVID- 19 vaccine ZyCoV-D. The latter is the first COVID-19 vaccine approved in India for adolescents in the 12-18 years age group.

“The management expects to start supplying the vaccine in India from Oct’21.
Based on our conservative estimates, we expect CDH to ramp-up production to
40 million doses from Oct’21. We expect a 75:25 split between the government and
private channel and a blended price of Rs 320 per dose for FY22,” Motilal Oswal Institutional Equities has said.

Cadila Healthcare expects to begin supplies of 100-120m doses of ZyCoV-D per annum starting mid-Sep’21. It is in discussions with the Government of India (GoI) with regard to its pricing and supply.

Cadila Healthcare is the only company manufacturing the drug substance for its vaccine. “Demand for the vaccine would be driven by requirement of an additional booster dose of other vaccines, scope for improvement in immunogenicity, and ability to protect from new COVID-19 variants. The management expects monthly sales of Rs 2-2.5 billion from Oct’21, which can be scaled up to a run-rate of Rs 5 billion per month. It has a marketing plan in place to drive demand through pediatricians/state government,” Motilal Oswal Institutional Equities has said in its report.

Valuation and view on Cadila Healthcare stock

“We arrive at an NPV of Rs 12 per share for the opportunity arising from the COVID-19 vaccine. We continue to value Cadila Healthcare base business at 25 times its 12-month forward earnings to arrive at our target price of Rs 658. We arrive at a target price of Rs 670, including the vaccine opportunity and maintain our Buy rating on the stock,” the brokerage has said.

Buy This Pharma Stock For 23% Gains, Says Motilal Oswal

Disclaimer

Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage houses are not liable for any losses caused as a result of decisions based on the article. The above article is for informational purposes only and is picked from the brokerage report of Sharekhan. Be careful while investing as the Sensex has now crossed 55,500 points. Investors can invest small amounts and avoid putting lumpsum.

Story first published: Tuesday, August 24, 2021, 10:36 [IST]



[ad_2]

CLICK HERE TO APPLY

Leave a comment

This Is A Stock To Buy That Can Yield 50% Returns, Says India’s Top Brokerage

Personal Finance

[ad_1]

Read More/Less


Buy Greaves Cotton for a price target of Rs 194

Current market price Rs 129.55
Target price Rs 194
Gains 49.88%

The brokerage sees a rally in the stock to levels of 194, from the current market price of around Rs 130. According to Sharekhan, Greaves Cotton reported weak performance in Q1FY22, marred by lockdown restrictions due to the second wave of COVID-19.

Standalone and consolidated net revenues declined 53.1% q-o-q and 56% q-o-q to Rs 214.4 crore and Rs 229 crore respectively in Q1FY22. The drop in revenue was due to lockdown restrictions. The 3W segments was down 72% q-o-q, while Ampere sales was impacted due to 8 weeks COVID led factory lockdown in Coimbatore. The consolidated gross margin improved 10 bps q-o-q to 28.6% in Q1FY22.

Rationale for buying the stock

Rationale for buying the stock

According to Sharekhan, the company’s management says it is witnessing strong recovery from July 2021 onwards. We expect Greaves Cotton to clock a 24% revenue CAGR during FY2021-23E also see a sharp rise in margins, leading to a 245% earnings CAGR,” the broking firm has said.

“Greaves has ramped up its e-mobility business at a much faster pace than we had anticipated earlier. Recently, Ampere has acquired a strategic stake in L5 e-3W manufacturer, MLR Auto, to operate as a full range last mile electric vehicle company with mass mobility solutions in both E-2W & E-3W segment. We believe Greaves Cotton is well positioned to benefit from the government’s push towards fast adoption of electrical vehicles.

We continue to maintain our positive stance on Greaves because of its timely investments in the e-mobility business. Greaves acquired Ampere in 2018 and now holds an 81.2% stake. Through its subsidiary Ampere, Greaves is setting up a EV mega site manufacturing facility at Ranipet, with a proposed investment plan of Rs. 700 crore to build capacity of producing one million e-2Ws in a phased manner over a period of 10 years,” the brokerage has said.

“In addition to its new venture in e-2W business, the company has incubated multi-businesses in-house, which includes non-auto engines, e-rick, mega/smart gensets, Greaves care (retail services arm), and multi-brand spares divisions. In our view, the refocus strategy has played well for the company, as Greaves Cotton has managed to display a strong quarterly revenue run-rate despite lacklustre sales in 3W engines with Q1FY22, being an exception,” the brokerage has said.

Sharekhan says that it maintains a buy on the stock Greaves Cotton Limited with an unchanged price target of Rs. 194, owing to positive business outlook for mobility business.

Disclaimer

Disclaimer

Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage houses are not liable for any losses caused as a result of decisions based on the article. The above article is for informational purposes only and is picked from the brokerage report of Sharekhan. Be careful while investing as the Sensex has now crossed 55,500 points. Investors can invest small amounts and avoid putting lumpsum.



[ad_2]

CLICK HERE TO APPLY

Leave a comment

3 Pharma Stocks To Buy As Suggested By Sharekhan For Double Digit Growth

Personal Finance

[ad_1]

Read More/Less


Buy Lupin with target price of Rs 1,400

Lupin is a renowned pharmaceutical company with a presence in nearly every market in the world. Sharekhan is positive on Lupin, recommending a buy rating and a target price of Rs 1400 in a research report.

According to the brokerage, in the short term, price erosion is projected to have an impact on the US business, but 2HFy2022 is expected to see a significant improvement due to the ramp up in Albuterol and Brovana. Launches in FY23 with high potential and limited competition provide the company even more room to grow.

“Lupin’s Q1FY22 operating results marginally missed estimates and so we have tweaked our earnings estimates for FY22E/FY23E. Given the robust growth outlook and the long term growth levers intact, and improving return ratios, we retain Buy on Lupin with an unchanged PT of Rs. 1,400.

Lupin’s domestic formulations business has a strong growth outlook and is expected to stage growth in the high teens for FY2022 backed by a chronic-heavy presence and growth in the overall business. The US business on the other hand is witnessing price erosion, which is expected to lead to a subdued Q2,” the brokerage has said.

Buy Cadila Healthcare with target of Rs 720

Buy Cadila Healthcare with target of Rs 720

Cadila Healthcare is a bullish stock, with Sharekhan recommending a buy rating and a target price of Rs 720 in its research report.

According to Sharekhan, the Indian business grew by 42.8 percent, with the human health business growing by a remarkable 63.6 percent. Cadila expects the DCGI to approve its COVID-19 vaccine ZyCoV-D for emergency use within the next two weeks.

“Strong growth prospects and earnings visibility, a sturdy balance sheet, healthy return ratios and multiple growth triggers are key positives for Cadila. We retain our Buy recommendation on the stock with unchanged PT of Rs. 720.

Cadila is developing a strong portfolio to treat the COVID-19 virus and this includes vaccines as well as drugs. Cadila has already applied with the DCGI seeking an emergency-use approval for its COVID-19 vaccine – ZyCov-D, the brokerage has said in its report.

Buy Aurobindo Pharma with a target of Rs 915

Buy Aurobindo Pharma with a target of Rs 915

Sharekhan is strong on Aurobindo Pharma, recommending a buy rating and a target price of Rs 915 in a research report.

“At CMP, the stock is trading at a valuation of 12.4x and 10.8x its FY22E and FY23E EPS, which is attractive. A possible de-merger of the injectables business could provide value

unlocking opportunities. Hence we retain our Buy recommendation on the stock with a revised

PT of Rs. 915, the brokerage has said.

According to Sharekhan, multiple challenges have surfaced, particularly for Aurobindo’s US business, such as increased price erosion and a build-up of stocks across channels. At least in the short term, these headwinds are projected to put downward pressure on US revenues.

Disclaimer

Disclaimer

Investing in stocks has the risk of financial loss. As a result, investors must proceed with prudence. Any losses incurred as a result of decisions based on the article are not the responsibility of Greynium Information Technologies, the author, or the brokerage houses. The preceding content is provided for informative purposes only and was taken from Sharekhan’s brokerage report. Due to the fact that the Sensex has now crossed 55,500 points, investors should exercise caution. Investors can invest little amounts rather than putting down a large chunk of money.



[ad_2]

CLICK HERE TO APPLY

Leave a comment
1 … 151 152 153 154 155 … 387